Cargando…
The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial
Objective: To evaluate the performance of cystatin C as a prognostic and predictive marker in a trial of patients with acute respiratory distress syndrome (ARDS). Design, patients and setting: A retrospective analysis was performed on plasma samples from patients included in the HARP-2 (hydroxymethy...
Autores principales: | McKelvey, Michael C., Bradbury, Ian, McDowell, Cliona, Calfee, Carolyn S., Weldon, Sinead, O'Kane, Cecilia M., McAuley, Daniel F., Taggart, Clifford C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692599/ https://www.ncbi.nlm.nih.gov/pubmed/38046206 http://dx.doi.org/10.51893/2022.3.OA4 |
Ejemplares similares
-
Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?
por: Reddy, Kiran, et al.
Publicado: (2021) -
The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview
por: Brown, Ryan, et al.
Publicado: (2020) -
COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021) -
Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial
por: Boyle, Andrew James, et al.
Publicado: (2022) -
Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence JM, et al.
Publicado: (2013)